MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that it is now offering its Panther Fusion ® SARS-CoV-2/Flu A/B/RSV assay and its Novodiag ® RESP-4 molecular ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic (Nasdaq: HOLX) announced today that it has completed regulatory filings needed to make Panther Trax ® available in a number of countries and regions.

Hologic, Inc. HOLX recently progressed in terms of the international launch of Panther Trax, representing the newest addition to the Panther Scalable Solutions (PSS) portfolio of products. The company ...

Marlborough medical device manufacturer Hologic has received U.S. Food and Drug Administration clearance for a new combined test that can detect influenza A and B, respiratory syncytial virus (RSV) ...

Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...